Sort
23,748 grants matching “melanoma”
p16 mechanisms in melanoma
$197,055Douglas Grossman · University Of Utah · R21 · FY2016 · CA
TCR/DAP10 chimera as a means to attaining persistent anti-tumor T cell responses
$197,055Jose Alejandro Guevara-Patino · Loyola University Chicago · R21 · FY2015 · CA
(PQC2) Resistance to fluid shear stress: a novel biomarker of cancer cells
$197,055Michael D. Henry · University Of Iowa · R21 · FY2013 · CA
Arsenic and health in Bangladesh
$197,000Harvard University (Sch Of Public Hlth) · P42 · FY2001 · ES
Arsenic and health in Bangladesh
$197,000Harvard University (Sch Of Public Hlth) · P42 · FY2000 · ES
Arsenic and health in Bangladesh
$197,000Harvard University (Sch Of Public Hlth) · P42 · FY2002 · ES
Translation of commensal bacteria mechanism for immunotherapy
$196,992Howard C Hang · Rockefeller University · R01 · FY2021 · CA
Core D: Medicinal Chemistry Core
$196,971Meenhard Herlyn · Wistar Institute · P01 · FY2016 · CA
Pro-melanomagenic role of Interferon-gamma: A paradigm shift
$196,953M. Raza Zaidi · Temple Univ Of The Commonwealth · K22 · FY2012 · CA
Pro-melanomagenic role of Interferon-gamma: A paradigm shift
$196,953M. Raza Zaidi · Temple Univ Of The Commonwealth · K22 · FY2013 · CA
Pro-melanomagenic role of Interferon-gamma: A paradigm shift
$196,953M. Raza Zaidi · Temple Univ Of The Commonwealth · K22 · FY2014 · CA
Core D: Medicinal Chemistry Core
$196,946Meenhard Herlyn · Wistar Institute · P01 · FY2017 · CA
KIR2DL2 Immune Checkpoint as Modulator of T-Cell Effector Function
$196,934Daniel Abate-Daga · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2023 · CA
Multifunctional Nanoprobe for Early Appraisal of Immunotherapeutic Efficacy
$196,875Srikanth Singamaneni · Washington University · R21 · FY2022 · EB
Generation of Highly Avid Anti-Tumor CTL for Optimal Adoptive Immunotherapy
$196,756Naoto Hirano · University Health Network · R01 · FY2014 · CA
Conditioning Patients to Increase DC-vaccine Potency
$196,688Joseph Wayne Fay · Baylor Research Institute · P01 · FY2007 · CA
Keratin proteins and non-melanoma skin tumors
$196,650Pierre Coulombe · Johns Hopkins University · R21 · FY2007 · CA
CAR mast cell for solid tumor
$196,646Xiaolei Su · Yale University · R21 · FY2025 · CA
MARSHALL U COBRE: B-CATENIN FUNCTION AND RETINOIC ACID IN MELANOMA
$196,581Beverly C Delidow · Marshall University · P20 · FY2008 · RR
Protein Kinase D and Epidermal Structure and Function
$196,466Wendy B Bollag · Augusta University · R21 · FY2010 · AR
Community Oriented Tool for Reducing Melanoma Health Disparities
$196,445Eric R. Craine · Western Research Company, Inc. · R43 · FY2012 · EB
TRIPTYCENE ANALOGS--NOVEL BIFUNCTIONAL ANTICANCER DRUGS
$196,425Kansas State University · R01 · FY2003 · CA
TRIPTYCENE ANALOGS--NOVEL BIFUNCTIONAL ANTICANCER DRUGS
$196,425Kansas State University · R01 · FY2002 · CA
TRIPTYCENE ANALOGS--NOVEL BIFUNCTIONAL ANTICANCER DRUGS
$196,425Kansas State University · R01 · FY2001 · CA
TRIPTYCENE ANALOGS--NOVEL BIFUNCTIONAL ANTICANCER DRUGS
$196,425Kansas State University · R01 · FY2004 · CA